Consistent with the role of ACE-2 in neutralizing ROS and decreasing angiotensin II, there is evidence that a persistent high activity of angiotensin II is at least in part responsible for the organ injury observed in COVID-19 (82, 83). The gene discussed is ACE2; the disease is COVID-19.